As a first step towards the elucidation of the systems biology of the model organism, Escherichia coli, it was our goal to mathematically model a metabolic system of intermediate complexity, the well-studied end-product regulated pathways for the biosynthesis of the branched chain amino acids, L-isoleucine, L- 
INTRODUCTION
Systems biology may be broadly defined as the integration of diverse data into useful biological models that allow scientists to easily observe complex cellular behaviors and to predict the outcomes of metabolic and genetic perturbations. As a first step towards the elucidation of the systems biology of the model organism, Escherichia coli, we have elected to limit our initial efforts to the development of a mathematical model for the complex but well-studied metabolic pathways for the biosynthesis of the branched chain amino acids, L-isoleucine, L-valine, and L-leucine.
The biosynthetic pathways for the branched chain amino acids are shown in Figure 1 (1-3) . Lthreonine deaminase (TDA), the first enzyme specific for the biosynthesis of L-isoleucine, is end-product inhibited by L-isoleucine, and α-isopropylmalate synthase (IPMS), the first enzyme specific for the biosynthesis of L-leucine, is end-product inhibited by L-leucine. However, because the parallel pathways for L-valine and L-isoleucine biosynthesis are catalyzed by a set of bi-functional enzymes that bind substrates from either pathway, L-valine inhibition of the first enzyme specific for its biosynthesis catalyzed by a single α-acetohydroxy acid synthase (AHAS) could compromise the cell for L-isoleucine biosynthesis or result in the accumulation of a toxic metabolic intermediate, α-ketobutyrate (αKB). This type of a regulatory problem is often solved by using multiple isozymes with different substrate preferences that are differentially regulated by multiple end-products of parallel pathways. In this case, there are three AHAS isozymes that catalyze the first step of the L-valine and the second step of the Lisoleucine pathway (4) . AHAS I has substrate preferences for the condensation of two pyruvate molecules required for L-valine biosynthesis, and is end-product inhibited by L-valine (4) . AHAS III shows no preference for pyruvate or αKB. While this isozyme can produce intermediates for both L-valine and Lisoleucine, it is inhibited by L-valine (4) . The AHAS II isozyme has substrate preferences for the condensation of pyruvate and αKB required for L-isoleucine biosynthesis, and it is not inhibited by any of the branched chain amino acids (4) . However, AHAS II is not active in the E. coli. K12 strain (5) .
Consequently, this strain cannot grow in the presence of high levels of L-valine unless L-isoleucine is also added to the growth medium (6) .
TDA is an allosteric enzyme whose kinetic behavior can be described by the concerted allosteric transition mode of Monod, Wyman, Changeux , the MWC model (7, 8) . According to the MWC model, TDA can exist in an active state (R) or an inactive state (T) (8, 9) . The fraction of active enzyme in the R or T states is determined by the concentrations and relative affinities of substrate (L-threonine), inhibitor (L-isoleucine), and activator (L-valine) for the R and T states.
In addition to these regulatory circuits, the intracellular levels of the branched chain amino acids are influenced by the reversible transamination reactions of each pathway. When the intracellular levels 3 of any of the end-product amino acids become high, reverse reactions to their cognate ketoacids are favored; for example, high concentrations of L-valine can be converted to α-ketoisovalerate (αKIV) to supplement L-leucine production. In turn, intracellular amino acid levels can be affected by their active transport from the extracellular growth medium. Therefore, the enzyme reactions required for the active transport of the branched chain amino acids into the cell against a concentration gradient are included in our simulations.
EXPERIMENTAL PROCEDURES

The Mathematical Model
Here we use kMech (10), a Cellerator (11) language extension that describes a suite of enzyme reaction mechanisms. Each enzyme mechanism is parsed by kMech into a set of fundamental associationdissociation reactions that are translated by Cellerator into ordinary differential equations (ODEs) that are numerically solved by Mathematica TM (10) . To build a model for a metabolic pathway, users need only to string together appropriate kMech enzyme mechanism models and to provide the physical and kinetic parameters for each enzyme. The development of approximation methods for estimating unavailable model parameters, such as forward and reverse rate constants (k f , k r ), from kinetic measurements (K m, k cat ) are described elsewhere (10).
The detailed kMech models for each of the pathway enzymes ( Fig. 1 
Carbon Flow Channeling
Traditional modeling approaches use the Michaelis-Menten kinetic equation for one substrate/one product reactions, and the King-Altman method to derive equations for more complex multiple reactant reactions. These types of equations focus on conversion between metabolites (metabolic flux) rather than 4 enzyme mechanisms. While metabolic flux provides valuable information about biomass conversions (12) , it cannot simulate, for example, the pathway-specific regulation patterns that control carbon flow channeling through the three AHAS isozymes of the parallel L-isoleucine and L-valine pathways, and the final transamination reactions. This level of mathematical modeling requires a detailed understanding of enzyme kinetic mechanisms and regulatory circuits (Fig. 2) as described below.
α-Acetohydroxy Acid Synthase (AHAS) Isozymes
The AHAS isozymes are controllers of carbon flow into either the L-isoleucine or L-valine biosynthetic pathway. The Ping Pong Bi Bi enzyme mechanism of these isozymes, describes a specialized two-substrate two-product (Bi Bi) mechanism in which the binding of substrates and release of products is ordered. It is a Ping Pong mechanism because the enzyme shuttles between a free and a substratemodified intermediate state indicated as white and shaded ovals, respectively, in Figure 2 .
Carbon flow through these isozymes is controlled by the affinities (K m ) of the enzyme intermediates for their second substrates as shown in Figure 2 (13) . For example, the AHAS II enzyme reactions shown in Figure 1 are described by the following reactions:
The first reaction set is for the condensation of two pyruvate (Pyr) molecules for the biosynthesis of α-acetolactate (αAL) of the L-valine and L-leucine pathways. The second reaction set is for the condensation of one Pyr molecule and one α -ketobutyrate (αKB) molecule for the biosynthesis of α-acetohydoxybutyrate (αAHB) of the L-isoleucine pathway. As written above, the initial reaction of Pyr with free AHAS II to form the activated enzyme intermediate is represented twice. Therefore, if these reactions were modeled, two molecules of Pyr would be consumed instead of just one for each molecule of Pyr or α KB produced. This redundancy can be resolved by rewriting these reactions as: 2 
These differential equations and variable definitions are passed to Mathematica TM where they are solved by the numeric solver (NDSolve) function and graphs of enzyme product vs. time are generated.
The Union operator also was used for the modeling of the L-valine inhibited AHAS I and AHAS III isozymes described in the supplemental data of the online version of this article. Detailed descriptions of other kMech models used in this simulation are published elsewhere (10) .
Reversible Transamination Mechanism
The pyridoxal 
Since the first substrate reaction with glutamate (Glu) is the same for all three of the branched chain α−ketoacid second substrates, the Mathematica TM Union operator is once again used to eliminate this redundancy. Because transamination is reversible, kMech models must be entered in both reaction directions for each of the three branched chain amino acid transaminations, and again the Union operator is used to eliminate the duplicated second substrate reactions (TBNH 2 + aKG ⇔ TBNH 2 ·aKG TB + Glu) of each transamination (gray arrowed lines in Fig. 2 ):
These reactions are parsed by kMech into elementary association-dissociation reactions and passed on to Cellerator where they are processed as described above. The same method was used for 8 modeling transaminase C (TC), a reversible Ping Pong Bi Bi mechanism enzyme that uses alanine as the amino donor for the transamination of L-valine (Fig. 2) .
Allosteric Regulation
Threonine deaminase (TDA) is an allosteric enzyme whose kinetic behavior can be described by the concerted allosteric transition model of Monod, Wyman, Changeux, the MWC model (7, 8) .
According to the MWC model, TDA can exist in an active state (R) or an inactive state (T) (8, 9) . The fraction of enzyme in the R or T state is determined by the concentrations and relative affinities of substrate (L-threonine), inhibitor (L-isoleucine), and activator (L-valine) for each state. This model is described by two equations: 
Approximation of Intracellular Enzyme Concentrations
With few exceptions, intracellular enzyme concentrations are not available. However, with careful experimental documentation, these concentrations can be approximated from the yields and specific activities of purified enzymes. For example, calculations based on purification tables in the literature suggest that the intracellular concentration of TDA is 4 µM (16). Furthermore, recent experiments have shown a positive correlation between mRNA levels measured with DNA microarrays and protein abundance in both E. coli (17) and yeast cells (18, 19) . Thus, the intracellular levels of the remaining enzymes of the branched chain amino acid biosynthetic pathway can be inferred from the calculated intracellular level of TDA and the relative mRNA levels of the other branched chain amino acid biosynthetic enzymes using DNA microarray data (20) . The data in Table 1 of the Supplemental Data in the online version of this article demonstrate that this is a reasonable method. Indeed, simulations using intracellular enzyme concentrations inferred in this manner produce experimentally observed steady state pathway intermediate, and end-product levels (21, 22) , usually within two-fold to one-half adjustments of these inferred values.
Optimization of Model Parameters
A list of reported enzyme kinetic and physical parameters needed to solve the differential equations for the simulations reported here and their literature sources are available in Table 1 Table 1 of the Supplemental Data of the online version of this article, it was used without further adjustment for the simulations of metabolic and genetic perturbations reported below.
RESULTS
Computational Modeling the Dynamics of Carbon Flow through the Branched Chain
Amino Acid Biosynthetic Pathways of E. coli K12
The three interacting metabolic pathways simulated here consist of eleven enzymes, eighteen metabolic intermediates, and three enzyme cofactors. The mathematical model for this metabolic system consists of 105 ordinary differential equations (ODEs), with 110 association and dissociation rate constants, and 52 catalytic rate constants. The enzymes of these interacting pathways employ three distinct enzyme mechanisms (simple catalytic, Bi Bi, and Ping Pong Bi Bi) that are regulated by allosteric, competitive, or noncomptetitive inhibition mechanisms. As described in the Methods section, the physical parameters for these models have been obtained directly from the literature, calculated from data in the literature, or estimated by fitting experimental data ( Table 1 of The steady state levels for the thirteen pathway intermediates and end-products are shown in Figure 3 . Steady-state enzyme activity levels were optimized to properly channel the steady-state flow of intermediates through these pathways to match reported in vivo levels of pathway intermediates and endproducts (21, 22) . The detailed kMech inputs, corresponding ODEs, kinetic rate constants, and initial conditions for solving the ODEs are presented in Figure 1 of the supplemental data available in the online version of this article.
Allosteric Regulation of L-Threonine Deaminase (TDA)
The allosteric regulatory mechanism of TDA was simulated with the MWC model employing physical parameters based on the literature or optimized to fit experimental data (10) . The data in Figure 3 show that TDA produces αKB at a steady state level comparable to that observed in vivo (21, 22) . Since the K i for L-isoleucine (15 µM) is much less than the K a for L-valine (550 µM), an initial decrease in the production of αKB as L-isoleucine accumulates is followed by an increase to a final steady level that accompanies the accumulation of L-valine (Fig. 3) . Correspondingly, the fraction of active TDA is initially decreased as L-isoleucine accumulates and countered to a steady level (5.5% of the total enzyme is in the active R state) while L-valine accumulates ( Figure 4A 
Regulation of the α-Acetohydroxyacid Synthase (AHAS) Isozymes
The two-substrate, two-product, AHAS isozymes I and III employ a Ping Pong Bi Bi enzyme mechanism described in the Methods section [the AHAS II isozyme is inactive in E. coli K12 (5)]. The L-valine inhibition of AHAS I and III is noncompetitive and, in the case of AHAS III, is incomplete since 15-20% of the activity attained at saturating substrate concentrations (V max ) remains in the presence of saturating L-valine concentrations (13) . The data in Figure 3 show that the production of αAL produced by AHAS isozymes I and III decreases as L-valine accumulates. These data also show that αAHB, primarily produced by AHAS isozyme III, decreases to a steady state level as its end-product inhibitor (Lvaline) accumulates, and as its substrate, αKB, decreases because L-isoleucine accumulates and inhibits TDA ( Figure 1 ).
Responses to Metabolic and Genetic Perturbations L-valine Growth Inhibition of Escherichia coli K12 is due to α-ketobutyrate (αKB)
Accumulation, not L-isoleucine Starvation
It is well known that adding L-valine at a final concentration of 1 mM to a culture of E. coli K12 cells growing in a glucose minimal salts medium inhibits their growth, and that this L-valine inhibition can be reversed by L-isoleucine addition (6) . Since the AHAS I and AHAS III isozymes of E. coli K12 strains are inhibited by L-valine, and since the ilvG gene for AHAS II in E. coli K12 strains contains a frameshift mutation that destroys AHAS II activity (5), it was assumed that L-valine inhibition of AHAS I and AHAS III might inhibit growth by interfering with L-isoleucine biosynthesis. However, later studies demonstrated that the intracellular L-isoleucine level is not suppressed by L-valine because its biosynthesis is sustained, even at saturating L-valine concentrations, by AHAS III that remains 15-20% active (13, 23) and by the L-valine activation of TDA that shuttles more substrate into the L-isoleucine pathway. Indeed, the simulation in Figure 5A shows that, in the presence of extra-cellular L-valine, the intra-cellular L-isoleucine level in fact accumulates nearly nine-fold ( Figure 5A ). At the same time, the pathway precursor of L-isoleucine, αKB, increases about four-fold ( Figure 5B ). This build-up of αKB is caused by L-valine activation of TDA ( Figure 5C ) which increases its production, and L-valine inhibition of the AHAS I and AHAS III isozymes, which reduces its consumption. It is now known that this αKB accumulation is toxic to cells because of its ability to inhibit the glucose PTS transport system (24, 25) . The simulation results in Figure 5B show that the growth inhibiting effects of L-valine induced αKB accumulation can be reversed by L-isoleucine by its ability to inhibit TDA activity. This simulation shows that, in the presence of 1 mM L-valine, the level of αKB increases around four-fold; and that in the presence of 500 µM L-isoleucine, αKB levels are reduced to the control level observed in the absence of L-valine. The simulation results in Figure 5C show that, concomitant with the rise in αKB observed in the presence of 1 mM L-valine, nearly 18% of the cellular TDA is converted to the active R state. However, concomitant with the decrease in αKB observed in the presence of 500 µM L-isoleucine, the cellular TDA in the active R state is reversed to the control level observed in the absence of L-valine. These simulations are verified by experimental results accumulated from multiple laboratories over a three decade period (6, 24, 25) .
Simulating the Metabolic Engineering of an L-Isoleucine Over-producing E. coli K12
Strain.
An obvious goal of modeling biological systems is to facilitate metabolic engineering for the commercial production of specialty chemicals such as amino acids. In the past, this has been largely accomplished by genetic manipulation and selection methods. For example, a common strategy to overproduce an amino acid has been to isolate a strain with a feedback resistant mutation in the gene for the first enzyme for the biosynthesis of that amino acid. Here we use our model to determine the effects of a feedback resistant TDA for the over-production of L-isoleucine. We can simulate a TDA feedback resistant mutant strain (TDA R ) by increasing the K i for L-isoleucine to a large number, (e.g. 100,000 µM).
The simulation in Figure 6A shows that in the absence of L-isoleucine inhibition, the activator and substrate ligands drive nearly 100% of cellular feedback resistant TDA R to the active R state compared to the wild type enzyme that is only 6% present in the active R state. However, in spite of this increased amount of enzyme in the active state, the data in Figure 6B show that AHAS III is able to support only a 5 to 6 fold increase in L-isoleucine production in a feedback resistant E. coli K12 compared to a wild type strain. At the same time, the steady state level of the AHAS III substrate, αKB, is increased about fortyfold ( Figure 6C ). This is because E. coli K12 does not have an active AHAS II isozyme that favors the condensation of pyruvate and αKB for L-isoleucine production; thus, αKB would accumulate to toxic levels. These simulation results suggest that in order to over-produce L-isoleucine, the αKB accumulation must be reduced. The results in Figure 6D show that restoring a wild type AHAS II isozyme and simulating an attenuator mutation that elevates the levels of all of the enzymes of the L-isoleucine and L-valine parallel pathways 11-fold (26), both avoids buildup of αKB and subsequent pathway intermediates ( Figure 6C) , and results in a forty-fold increase in L-isoleucine production. These simulated results that
show that high level overproduction of L-isoleucine in E. coli requires a functional AHAS II isozyme and a de-attenuated genetic background (ilvGMEDA-att -) agree with experiments performed by Hashiguchi et al. of the Ajinomoto Co., Tokyo, Japan (27) .
Excess L-Valine Supplements L-Leucine Synthesis
An Escherichia coli K12 ilvC strain lacking IR activity cannot produce α,β-dihydroxy-isovalerate 
DISCUSSION
In this report, we describe a mathematical simulation of branched chain amino acid biosynthesis and regulation in E. coli. This approach involves the following steps:
1. The identification of all the molecular participants including enzymes, metabolites, and coenzymes, as well as the enzyme kinetic and regulatory mechanism of each enzyme (defined in Figure 1 and Table 1 and bind in a site-specific manner to one or a few DNA sites to regulate single operons. Each of these levels of control impacts metabolic regulation by influencing enzyme levels. Thus, a complete model of branched chain amino acid biosynthesis in E. coli must include these higher levels of gene regulation. To incorporate these higher levels of regulation we are currently developing a set of models that describe the genetic regulatory mechanisms that control the operons of the ilv regulon. To these ends, we face new challenges. For example, while the ordinary differential equations we are using for metabolic pathways are a deterministic and continuous approximation for an average representation of interactions between large numbers of discrete molecules (e.g. enzymes and metabolites), McAdams and Arkin point out that because each cell contains only one gene/operon there can be large differences in the time between successive events in regulatory cascades across a cell population that can produce probabilistic outcomes (36) . To address this and other issues, we are currently working on another software package for genetic regulatory mechanisms, gMech, that implements stochastic simulation algorithms such as Gillespie's algorithm (37) , and the Langevin equation (38) that accommodate stochastic noise. This gMech software package will contain models for genetic regulatory mechanisms such as attenuation, activation and repression, as well as DNA topological controls. Therefore, the work presented here should be considered as a first step of a "bottom up" approach that integrates biochemical information from the literature and bioinformatics databases, and relative gene expression data from DNA microarrays to build a self-regulated metabolic pathway in E. coli. As high throughput technologies for genomics, proteomics and metabolomics grow, we expect that a similar approach will soon be feasible in higher organisms. (Fig. 3A) . 
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